FDA highlights the increasing relevance of cybersecurity in the context of medical device safety and effectiveness in the opening section of the final guidance issued on June 27, 2025:
With the increasing integration of wireless, Internet- and network-connected capabilities, portable media (e.g., USB or CD), and the frequent electronic exchange of medical device-related health information and other information, the need for robust cybersecurity controls to ensure medical device safety and effectiveness has become more important.
Further;
In addition, cybersecurity threats to the healthcare sector have become more frequent and more severe, carrying increased potential for clinical impact. Cyber incidents have rendered medical devices and hospital networks inoperable, disrupting the delivery of patient care across healthcare facilities in the U.S. and globally. Such cyber incidents and exploits may lead to patient harm as a result of clinical hazards, such as delay in diagnoses and/or treatment.
It is important to view FDA’s expectations outlined in this final guidance from the perspective outlined above. Cybersecurity is not an add-on; rather it is now considered to be an essential factor in assessing medical device safety and effectiveness throughout its total product lifecycle.
A risk-based approach is recommended to compile documentation for pre-market review, and continued surveillance and actions in the post-market phase.
🎧Listen to a brief audio summary of this guidance and recommendations QA/RA and Risk professionals can apply in practice.
Note:
The audio summary was prepared using Google NotebookLM1, an AI-enabled research tool. Here is the list of resources used for this analysis:
FDA: Final Guidance for Cybersecurity in Medical Devices, Issued June 27, 2025.
FDA: Draft Guidance for Cybersecurity in Medical Devices, Issued September 27, 2023.
FDA: Cybersecurity in Medical Devices Frequently Asked Questions, Website accessed July 01, 2025
Google: NotebookLM, accessed July 01, 2025.
Share this post